SOPs for Pharmacovigilance

The purpose of this SOP is to outline procedures for the reporting of adverse events (AEs) associated with pharmaceutical products.
Click to read the full article.

The purpose of this SOP is to outline procedures for the management and reporting of serious adverse events (SAEs) related to pharmaceutical products.
Click to read the full article.

The purpose of this SOP is to establish procedures for the management and reporting of pharmacovigilance incidents and non-serious adverse events.
Click to read the full article.

The purpose of this SOP is to outline procedures for monitoring and ensuring compliance with pharmacovigilance regulations and guidelines.
Click to read the full article.

The purpose of this SOP is to establish procedures for conducting post-marketing surveillance (PMS) to monitor the safety of pharmaceutical products after they have been authorized for use.
Click to read the full article.

The purpose of this SOP is to outline procedures for developing and implementing Risk Evaluation and Mitigation Strategies (REMS) in pharmacovigilance.
Click to read the full article.

The purpose of this SOP is to establish procedures for ensuring pharmacovigilance activities are inspection-ready at all times.
Click to read the full article.

The purpose of this SOP is to outline procedures for preparing pharmacovigilance activities and documentation for internal and external audits.
Click to read the full article.

The purpose of this SOP is to establish procedures for conducting quality control checks in pharmacovigilance to ensure data accuracy, completeness, and compliance with regulatory requirements.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for responding to medical inquiries related to pharmacovigilance.
Click to read the full article.